Welcome to our dedicated page for Cronos Group SEC filings (Ticker: CRON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Cronos Group Inc. (CRON), a cannabinoid-focused company listed on NASDAQ and the Toronto Stock Exchange. As a foreign private issuer incorporated in British Columbia, Canada, Cronos files reports with the SEC under Commission File Number 001-38403, giving investors structured insight into its operations, governance and financial condition.
Cronos’ SEC disclosure includes current reports on Form 8-K, which the company uses to announce material events. Recent 8-K filings have covered quarterly financial results, such as press releases for the second and third quarters of 2025, and corporate governance matters, including the appointment and subsequent termination of the company’s principal accounting officer and the results of the 2025 Annual Meeting of Shareholders. These filings provide detail on topics like voting outcomes for director elections, advisory votes on executive compensation and the appointment of the independent auditor.
Through this filings page, users can also review Cronos’ periodic reports (such as annual and quarterly filings referenced in its 8-Ks) to understand trends in revenue, gross profit, adjusted EBITDA and other metrics the company discusses in its earnings materials. The filings describe elements of Cronos’ business, including its cannabis brands, international operations and investments such as its interest in Cronos Growing Company Inc. (Cronos GrowCo).
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify important changes in financial performance, governance or strategy. Real-time updates from the EDGAR system ensure that new Cronos 8-Ks, 10-K equivalents for foreign issuers, 10-Q equivalents and proxy materials are added as they are filed, while insider transaction reports on Form 4, if applicable, can be used to monitor share dealings by directors and officers.
By combining Cronos’ official SEC filings with AI-generated explanations, this page is designed to make the company’s regulatory disclosures more accessible to investors, analysts and other stakeholders.
On 7 Aug 2025 Cronos Group Inc. (NASDAQ: CRON) filed a Form 8-K disclosing two matters:
- Item 2.02 – Results of Operations: the company issued a press release (Exhibit 99.1) containing its Q2-2025 financial results for the period ended 30 Jun 2025. Specific revenue, earnings or guidance figures are not included in the 8-K body; investors must refer to the attached exhibit for details.
- Item 5.02 – Officer change: effective immediately after the forthcoming Form 10-Q, the Board appointed Lloyd Wilson (53), currently Vice President & Controller, as Principal Accounting Officer. Wilson brings 20+ years of GAAP and SEC-reporting experience, most recently as Corporate Controller at Vital Farms (Nov 2021–Jun 2025) and previously as an auditor at Grant Thornton and KPMG. He replaces James McGinness, who departs the company on the same date.
The filing notes no family relationships, related-party transactions or special arrangements tied to Wilson’s selection. Other sections are routine, and no forward-looking guidance was provided.